Wanbury Limited (WANBURY) - Total Assets
Based on the latest financial reports, Wanbury Limited (WANBURY) holds total assets worth Rs4.57 Billion INR (≈ $49.38 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Wanbury Limited - Total Assets Trend (2006–2025)
This chart illustrates how Wanbury Limited's total assets have evolved over time, based on quarterly financial data. Also see Wanbury Limited market cap and net worth for the company's overall valuation and market capitalisation.
Wanbury Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Wanbury Limited's total assets of Rs4.57 Billion consist of 46.7% current assets and 53.3% non-current assets. Review debt load of Wanbury Limited to assess the company's total debt and financial obligations.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs87.68 Million | 1.0% |
| Accounts Receivable | Rs1.14 Billion | 27.6% |
| Inventory | Rs376.80 Million | 9.1% |
| Property, Plant & Equipment | Rs2.06 Billion | 49.7% |
| Intangible Assets | Rs2.28 Million | 0.1% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2006–2025)
This chart illustrates how Wanbury Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Wanbury Limited (WANBURY) share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Wanbury Limited's current assets represent 46.7% of total assets in 2025, a decrease from 49.4% in 2006.
- Cash Position: Cash and equivalents constituted 1.0% of total assets in 2025, down from 5.5% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 27.0% in 2006.
- Asset Diversification: The largest asset category is property, plant & equipment at 49.7% of total assets.
Wanbury Limited Competitors by Total Assets
Key competitors of Wanbury Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Yunnan Baiyao Group Co Ltd
SHE:000538
|
China | CN¥53.34 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Jiuzhitang Co Ltd
SHE:000989
|
China | CN¥5.73 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
Wanbury Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.21 | 0.86 | 0.31 |
| Quick Ratio | 0.96 | 0.69 | 0.26 |
| Cash Ratio | 0.03 | 0.03 | 0.00 |
| Working Capital | Rs393.31 Million | Rs-304.06 Million | Rs-2.35 Billion |
Wanbury Limited - Advanced Valuation Insights
This section examines the relationship between Wanbury Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.30 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 20.5% |
| Total Assets | Rs4.14 Billion |
| Market Capitalization | $84.17 Million USD |
Valuation Analysis
Below Book Valuation: The market values Wanbury Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Wanbury Limited's assets grew by 20.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Wanbury Limited (2006–2025)
The table below shows the annual total assets of Wanbury Limited from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs4.14 Billion ≈ $44.76 Million |
+20.50% |
| 2024-03-31 | Rs3.43 Billion ≈ $37.15 Million |
+13.17% |
| 2023-03-31 | Rs3.04 Billion ≈ $32.82 Million |
-13.91% |
| 2022-03-31 | Rs3.53 Billion ≈ $38.13 Million |
+21.91% |
| 2021-03-31 | Rs2.89 Billion ≈ $31.27 Million |
+3.76% |
| 2020-03-31 | Rs2.79 Billion ≈ $30.14 Million |
-2.57% |
| 2019-03-31 | Rs2.86 Billion ≈ $30.93 Million |
+4.89% |
| 2018-03-31 | Rs2.73 Billion ≈ $29.49 Million |
-33.79% |
| 2017-03-31 | Rs4.12 Billion ≈ $44.55 Million |
+7.73% |
| 2016-03-31 | Rs3.82 Billion ≈ $41.35 Million |
-3.38% |
| 2015-03-31 | Rs3.96 Billion ≈ $42.80 Million |
-2.54% |
| 2014-03-31 | Rs4.06 Billion ≈ $43.91 Million |
-47.46% |
| 2013-03-31 | Rs7.73 Billion ≈ $83.59 Million |
-4.70% |
| 2012-03-31 | Rs8.11 Billion ≈ $87.71 Million |
+6.51% |
| 2011-03-31 | Rs7.61 Billion ≈ $82.34 Million |
-5.59% |
| 2010-03-31 | Rs8.06 Billion ≈ $87.21 Million |
-3.27% |
| 2009-03-31 | Rs8.34 Billion ≈ $90.16 Million |
+160.17% |
| 2007-03-31 | Rs3.20 Billion ≈ $34.65 Million |
+64.39% |
| 2006-03-31 | Rs1.95 Billion ≈ $21.08 Million |
-- |
About Wanbury Limited
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines,… Read more